Menu

Traverse 2024 Testosterone

Traverse 2024 Testosterone. In a video interview at the 24th annual fall scientific meeting of sexual medicine society of north america in san diego, california, mohit khera, md, mba,. Khera begins by reviewing the history of the traverse trial and its initial results regarding the impact of testosterone therapy on cardiovascular health.


Traverse 2024 Testosterone

A substudy of the randomized traverse trial showed no slowing of diabetes progression with testosterone therapy in hypogonadism. A small trial of testosterone in older men, the tom trial, was stopped early by the data safety monitoring committee because of what appeared to be an excess risk of.

Traverse 2024 Testosterone Images References :